Single-cell RNA sequencing highlights the role of epithelial-immune dual features of proximal tubule cells in BK polyomavirus nephropathy.

IF 3.8 2区 医学 Q2 VIROLOGY
Feng Yang, Xutao Chen, Hui Zhang, Shicong Yang, Huifei Yang, Peisong Chen, Guodong Zhao, Yingzhen He, Siyan Meng, Dongfeng Yin, Qian Li, Jiang Qiu, Gang Huang
{"title":"Single-cell RNA sequencing highlights the role of epithelial-immune dual features of proximal tubule cells in BK polyomavirus nephropathy.","authors":"Feng Yang, Xutao Chen, Hui Zhang, Shicong Yang, Huifei Yang, Peisong Chen, Guodong Zhao, Yingzhen He, Siyan Meng, Dongfeng Yin, Qian Li, Jiang Qiu, Gang Huang","doi":"10.1128/jvi.01394-25","DOIUrl":null,"url":null,"abstract":"<p><p>Up to 10% of renal allograft failures are caused by BK polyomavirus nephropathy (BKPyVN). However, there is no specific antiviral agent for BKPyVN. The only treatment is to reduce the levels of immunosuppression, which is not always practical and increases the risk of rejection. Since targeting the microenvironment is a promising approach, we performed single-cell RNA sequencing (scRNA-seq) on BKPyVN samples and stable allografts to obtain BKPyVN microenvironmental atlases. Interestingly, we identified a novel subpopulation of proximal tubule cells (annotated as IGKC+ PT) with epithelial-immune dual features that may contribute to the progression of BKPyVN through T-cell exhaustion. Additionally, we determined that the IGKC+ PT subpopulation might serve as a non-invasive diagnostic marker through scRNA-seq of urine samples and co-immunofluorescence staining. These results improve our understanding of the BKPyVN microenvironment and may guide the development of new therapeutic and diagnostic approaches for a wide range of patients.IMPORTANCEBKPyVN severely threatens kidney transplant recipients. Due to the lack of effective drugs against BK polyomavirus (BKPyV), reducing immunosuppressant therapy is the only treatment. Unfortunately, this approach is not always effective and increases the acute rejection risk. A growing body of research suggests that potential therapeutic targets may be identified by studying the disease microenvironment. However, traditional methods have not explained why the large number of infiltrating T cells in the BKPyVN microenvironment does not effectively clear BKPyV. Newly available large-scale scRNA-seq technology can be used to study gene expression at a single-cell resolution, offering a new way to investigate the BKPyVN microenvironment. By combining scRNA-seq with experimental analysis, we found a novel subpopulation of proximal tubule cells (annotated as IGKC+ PT) with epithelial-immune dual features that may contribute to the progression of BKPyVN through T-cell exhaustion.</p>","PeriodicalId":17583,"journal":{"name":"Journal of Virology","volume":" ","pages":"e0139425"},"PeriodicalIF":3.8000,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Virology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1128/jvi.01394-25","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Up to 10% of renal allograft failures are caused by BK polyomavirus nephropathy (BKPyVN). However, there is no specific antiviral agent for BKPyVN. The only treatment is to reduce the levels of immunosuppression, which is not always practical and increases the risk of rejection. Since targeting the microenvironment is a promising approach, we performed single-cell RNA sequencing (scRNA-seq) on BKPyVN samples and stable allografts to obtain BKPyVN microenvironmental atlases. Interestingly, we identified a novel subpopulation of proximal tubule cells (annotated as IGKC+ PT) with epithelial-immune dual features that may contribute to the progression of BKPyVN through T-cell exhaustion. Additionally, we determined that the IGKC+ PT subpopulation might serve as a non-invasive diagnostic marker through scRNA-seq of urine samples and co-immunofluorescence staining. These results improve our understanding of the BKPyVN microenvironment and may guide the development of new therapeutic and diagnostic approaches for a wide range of patients.IMPORTANCEBKPyVN severely threatens kidney transplant recipients. Due to the lack of effective drugs against BK polyomavirus (BKPyV), reducing immunosuppressant therapy is the only treatment. Unfortunately, this approach is not always effective and increases the acute rejection risk. A growing body of research suggests that potential therapeutic targets may be identified by studying the disease microenvironment. However, traditional methods have not explained why the large number of infiltrating T cells in the BKPyVN microenvironment does not effectively clear BKPyV. Newly available large-scale scRNA-seq technology can be used to study gene expression at a single-cell resolution, offering a new way to investigate the BKPyVN microenvironment. By combining scRNA-seq with experimental analysis, we found a novel subpopulation of proximal tubule cells (annotated as IGKC+ PT) with epithelial-immune dual features that may contribute to the progression of BKPyVN through T-cell exhaustion.

单细胞RNA测序强调了近端小管细胞在BK多瘤病毒肾病中上皮免疫双重特征的作用。
高达10%的同种异体肾移植失败是由BK多瘤病毒肾病(BKPyVN)引起的。然而,目前还没有针对BKPyVN的特异性抗病毒药物。唯一的治疗方法是降低免疫抑制水平,但这并不总是可行的,而且会增加排斥反应的风险。由于靶向微环境是一种很有前途的方法,我们对BKPyVN样本和稳定的同种异体移植物进行了单细胞RNA测序(scRNA-seq),以获得BKPyVN微环境图谱。有趣的是,我们发现了一种新的近端小管细胞亚群(注释为IGKC+ PT),具有上皮免疫双重特征,可能通过t细胞衰竭促进BKPyVN的进展。此外,我们确定IGKC+ PT亚群可以通过尿液样本的scrna测序和共免疫荧光染色作为非侵入性诊断标志物。这些结果提高了我们对BKPyVN微环境的理解,并可能指导为广泛的患者开发新的治疗和诊断方法。重要bkpyvn严重威胁肾移植受者。由于缺乏针对BK多瘤病毒(BKPyV)的有效药物,减少免疫抑制治疗是唯一的治疗方法。不幸的是,这种方法并不总是有效的,而且增加了急性排斥反应的风险。越来越多的研究表明,通过研究疾病微环境可以确定潜在的治疗靶点。然而,传统的方法并没有解释为什么大量浸润在BKPyVN微环境中的T细胞不能有效清除BKPyV。新出现的大规模scRNA-seq技术可用于单细胞分辨率下的基因表达研究,为研究BKPyVN微环境提供了新的途径。通过将scRNA-seq与实验分析相结合,我们发现了一种新的近端小管细胞亚群(注释为IGKC+ PT)具有上皮免疫双重特征,可能通过t细胞耗竭促进BKPyVN的进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Virology
Journal of Virology 医学-病毒学
CiteScore
10.10
自引率
7.40%
发文量
906
审稿时长
1 months
期刊介绍: Journal of Virology (JVI) explores the nature of the viruses of animals, archaea, bacteria, fungi, plants, and protozoa. We welcome papers on virion structure and assembly, viral genome replication and regulation of gene expression, genetic diversity and evolution, virus-cell interactions, cellular responses to infection, transformation and oncogenesis, gene delivery, viral pathogenesis and immunity, and vaccines and antiviral agents.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信